Vimarsana
Biggest News Aggregation in the World

Companion Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Companion Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Companion Sciences Today - Breaking & Trending Today

Kazmira and Companion Sciences Announce Strategic Partnership to Commercialize Revolutionary New CBD Joint Mobility Product - Vimarsana News

Kazmira and Companion Sciences Announce Strategic Partnership to Commercialize Revolutionary New CBD Joint Mobility Product

(Watkins, CO  – February 21, 2022) – Kazmira, a vertically integrated cannabinoid manufacturer with patent protected purification technology – who received a $50M minority investment from Perrigo, (NYSE: PRGO) in June of 2020 – today announced a significant strategic partnership with Companion Sciences to utilize its patent-pending CBD+Glucosamine formula and

Kazmira Announces Partnership with Companion Sciences - Vimarsana News

Kazmira Announces Partnership with Companion Sciences

(Watkins, CO  – January 14, 2022) – Kazmira, a vertically integrated cannabinoid manufacturer with patent protected purification technology – who received a $50M minority investment from Perrigo, (NYSE: PRGO) in June of 2020 – today announced a significant strategic partnership with Companion Sciences to utilize its patent-pending CBD+Glucosamine formula and

Kazmira, The Cannabinoid Company, Announces Strategic Partnership with Companion Sciences to Commercialize a Revolutionary New CBD Joint Mobility Product - Vimarsana News

Kazmira, The Cannabinoid Company, Announces Strategic Partnership with Companion Sciences to Commercialize a Revolutionary New CBD Joint Mobility Product

(Watkins, CO  – January 14, 2022) – Kazmira, a vertically integrated cannabinoid manufacturer with patent protected purification technology – who received a $50M minority investment from Perrigo, (NYSE: PRGO) in June of 2020 – today announced a significant strategic partnership with Companion Sciences to utilize its patent-pending CBD+Glucosamine formula and